| HGNC Family | Immunoglobulin superfamily domain containing |
| Name | V-set and transmembrane domain containing 5 |
| Description | Predicted to be involved in several processes, including filopodium assembly; positive regulation of excitatory synapse assembly; and protein homooligomerization. Predicted to be located in membrane. Predicted to be active in axon; dendrite; and plasma membrane. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nNotably, none of the provided abstracts address VSTM5. Instead, the studies focus on the sodium taurocholate cotransporting polypeptide (NTCP; gene SLC10A1) and its multifaceted role in hepatocyte function. NTCP is shown to be critical for the hepatic uptake of conjugated bile acids and, importantly, acts as a receptor mediating the entry of hepatitis B and D viruses into susceptible cells. Its proper function ensures bile acid homeostasis and influences viral infectivity, as illustrated by its species‐specific domains that determine viral entry competence."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "5"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA second major theme among these abstracts is the regulation of NTCP expression and activity at both the transcriptional and post‐translational levels. Multiple studies detail how nuclear receptors and hepatocyte‐enriched transcription factors (for example, HNF-4α, HNF-1α, RXRα/RARα, and C/EBPβ) govern NTCP gene expression in a species-specific manner. In addition, NTCP function is modified by cellular signals such as bile acid accumulation, cytokine exposure, and chemical challenges—including exposure to perfluorinated compounds and drugs such as isoniazid and rifampicin—that can down-regulate its expression and activity. These findings illustrate the complex interplay between metabolic, chemical, and inflammatory signals in modulating NTCP-mediated bile acid uptake."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "6", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA third important aspect discussed in these studies is the relevance of NTCP in disease contexts and physiological adaptations. In models of cholestasis, liver regeneration after partial hepatectomy, and certain drug-induced liver injuries, altered NTCP expression contributes to the compensatory adjustments of bile acid synthesis, detoxification, and transporter activity. Moreover, genetic deletion or pharmacological inhibition of NTCP not only affects bile acid clearance but may also modulate energy homeostasis and susceptibility to obesity and hepatic steatosis. Collectively, these observations underscore NTCP’s pivotal role within the enterohepatic circulation and its potential as a therapeutic target. It is important to bear in mind that while these abstracts provide a wealth of insight into NTCP function and regulation, they do not offer any information on VSTM5, suggesting that the role of VSTM5 remains to be defined in these contexts."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Henk Wolters, Baukje M Elzinga, Julius F W Baller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of bile salt flux variations on the expression of hepatic bile salt transporters in vivo in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hepatol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/s0168-8278(02)00247-7"}], "href": "https://doi.org/10.1016/s0168-8278(02"}, {"type": "t", "text": "00247-7) PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12399219"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12399219"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Diana Jung, Bruno Hagenbuch, Michael Fried, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of liver-enriched transcription factors and nuclear receptors in regulating the human, mouse, and rat NTCP gene."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00456.2003"}], "href": "https://doi.org/10.1152/ajpgi.00456.2003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14701722"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14701722"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Gernot Zollner, Martin Wagner, Peter Fickert, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00319.2004"}], "href": "https://doi.org/10.1152/ajpgi.00319.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16002565"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16002565"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Tohru Saeki, Yuki Munetaka, Kazumitsu Ueda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of Ala substitution for conserved Cys residues in mouse ileal and hepatic Na+-dependent bile acid transporters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Biotechnol Biochem (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1271/bbb.70037"}], "href": "https://doi.org/10.1271/bbb.70037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17690477"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17690477"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Xingguo Cheng, David Buckley, Curtis D Klaassen "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of hepatic bile acid transporters Ntcp and Bsep expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Pharmacol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bcp.2007.08.014"}], "href": "https://doi.org/10.1016/j.bcp.2007.08.014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17897632"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17897632"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Xingguo Cheng, Curtis D Klaassen "}, {"type": "b", "children": [{"type": "t", "text": "Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Toxicol Sci (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/toxsci/kfn161"}], "href": "https://doi.org/10.1093/toxsci/kfn161"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18703564"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18703564"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Satoki Imai, Ryota Kikuchi, Hiroyuki Kusuhara, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Analysis of DNA methylation and histone modification profiles of liver-specific transporters."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Pharmacol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1124/mol.108.052589"}], "href": "https://doi.org/10.1124/mol.108.052589"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19047482"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19047482"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Iván L Csanaky, Lauren M Aleksunes, Yuji Tanaka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.90728.2008"}], "href": "https://doi.org/10.1152/ajpgi.90728.2008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19497955"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19497955"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Nathan J Cherrington, Teresa E Estrada, Harrison A Frisk, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The hepatic bile acid transporters Ntcp and Mrp2 are downregulated in experimental necrotizing enterocolitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Physiol Gastrointest Liver Physiol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1152/ajpgi.00317.2012"}], "href": "https://doi.org/10.1152/ajpgi.00317.2012"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23125159"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23125159"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Huan Yan, Bo Peng, Wenhui He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.03540-12"}], "href": "https://doi.org/10.1128/JVI.03540-12"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23678176"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23678176"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Davor Slijepcevic, Christina Kaufman, Catharina G K Wichers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Impaired uptake of conjugated bile acids and hepatitis b virus pres1-binding in na(+) -taurocholate cotransporting polypeptide knockout mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.27694"}], "href": "https://doi.org/10.1002/hep.27694"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25641256"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25641256"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Annika Sommerfeld, Patrick G K Mayer, Miriam Cantore, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of plasma membrane localization of the Na+-taurocholate cotransporting polypeptide (Ntcp) by hyperosmolarity and tauroursodeoxycholate."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M115.666883"}], "href": "https://doi.org/10.1074/jbc.M115.666883"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26306036"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26306036"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Davor Slijepcevic, Reinout L P Roscam Abbing, Takeshi Katafuchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatic uptake of conjugated bile acids is mediated by both sodium taurocholate cotransporting polypeptide and organic anion transporting polypeptides and modulated by intestinal sensing of plasma bile acid levels in mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.29251"}], "href": "https://doi.org/10.1002/hep.29251"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28498614"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28498614"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Fengfeng Mao, Teng Liu, Xinfeng Hou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased sulfation of bile acids in mice and human subjects with sodium taurocholate cotransporting polypeptide deficiency."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.RA118.007179"}], "href": "https://doi.org/10.1074/jbc.RA118.007179"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31201272"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31201272"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Joanne M Donkers, Sander Kooijman, Davor Slijepcevic, et al. "}, {"type": "b", "children": [{"type": "t", "text": "NTCP deficiency in mice protects against obesity and hepatosteatosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "JCI Insight (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/jci.insight.127197"}], "href": "https://doi.org/10.1172/jci.insight.127197"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31237863"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31237863"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yujie Yang, Lei Liu, Xiqian Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tanshinone IIA prevents rifampicin-induced liver injury by regulating BSEP/NTCP expression via epigenetic activation of NRF2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Liver Int (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/liv.14262"}], "href": "https://doi.org/10.1111/liv.14262"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31571363"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31571363"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ahmad Salhab, Johnny Amer, Yinying Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Sodium"}, {"type": "a", "children": [{"type": "t", "text": "sup"}], "href": "sup"}, {"type": "t", "text": "+"}, {"type": "a", "children": [{"type": "t", "text": "/sup"}], "href": "/sup"}, {"type": "t", "text": "/taurocholate cotransporting polypeptide as target therapy for liver fibrosis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gut (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/gutjnl-2020-323345"}], "href": "https://doi.org/10.1136/gutjnl-2020-323345"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34266968"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34266968"}]}]}]}
|
| Synonyms | C11ORF90 |
| Proteins | VSTM5_HUMAN |
| NCBI Gene ID | 387804 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
VSTM5 has 2,757 functional associations with biological entities spanning 9 categories (molecular profile, organism, functional term, phrase or reference, disease, phenotype or trait, chemical, structural feature, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 61 datasets.
Click the + buttons to view associations for VSTM5 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of VSTM5 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of VSTM5 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of VSTM5 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of VSTM5 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Mouse Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of VSTM5 gene relative to other cell types and tissues from the BioGPS Mouse Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of VSTM5 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with VSTM5 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of VSTM5 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of VSTM5 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of VSTM5 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of VSTM5 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing VSTM5 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing VSTM5 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with VSTM5 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of VSTM5 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with VSTM5 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by VSTM5 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with VSTM5 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at VSTM5 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of VSTM5 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of VSTM5 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing VSTM5 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing VSTM5 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of VSTM5 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of VSTM5 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of VSTM5 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of VSTM5 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of VSTM5 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2023 | biological processes involving VSTM5 gene from the curated GO Biological Process Annotations 2023 dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving VSTM5 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing VSTM5 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2023 | cellular components containing VSTM5 protein from the curated GO Cellular Component Annotations 2023 dataset. | |
| GO Cellular Component Annotations 2025 | cellular components containing VSTM5 protein from the curated GO Cellular Component Annotations 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of VSTM5 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of VSTM5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of VSTM5 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of VSTM5 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with VSTM5 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with VSTM5 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of VSTM5 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of VSTM5 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of VSTM5 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of VSTM5 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for VSTM5 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of VSTM5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of VSTM5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of VSTM5 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of VSTM5 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain VSTM5 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by VSTM5 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of VSTM5 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of VSTM5 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of VSTM5 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of VSTM5 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at VSTM5 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of VSTM5 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of VSTM5 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of VSTM5 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of VSTM5 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of VSTM5 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with VSTM5 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |